Literature DB >> 11932212

Acute vertebral body compression fractures: discrimination between benign and malignant causes using apparent diffusion coefficients.

J H M Chan1, W C G Peh, E Y K Tsui, L F Chau, K K Cheung, K B Chan, M K Yuen, E T H Wong, K P C Wong.   

Abstract

Diffusion weighted MRI was performed on patients with acute vertebral body compression. The usefulness of the apparent diffusion coefficient (ADC) in differentiating between benign and malignant fractures was evaluated. A total of 49 acute vertebral body compression fractures were found in 32 patients. 25 fractures in 18 patients were due to osteoporosis, 18 fractures in 12 patients were histologically proven to be due to malignancy, and 6 fractures in 2 patients were due to tuberculosis. Signal intensities on T(1) weighted, short tau inversion recovery (STIR) and diffusion weighted images were compared. ADC values of normal and abnormal vertebral bodies were calculated. Except for two patients with sclerotic metastases, benign acute vertebral fractures were hypointense and malignant acute vertebral fractures were hyperintense with respect to normal bone marrow on diffusion weighted images. Mean combined ADCs (ADC(cmb); average of the combined ADCs in the x, y and z diffusion directions) were 0.23 x 10(-3) mm(2) s(-1) in normal vertebrae, 0.82 x 10(-3) mm(2) s(-1) in malignant acute vertebral fractures and 1.94 x 10(-3) mm(2) s(-1) in benign acute vertebral fractures. The differences between ADC(cmb) values were statistically significant (p<0.001). The ADC is useful in differentiating benign from malignant acute vertebral body compression fractures, but there may be overlapping ADC values between malignant fractures and tuberculous spondylitis.

Entities:  

Mesh:

Year:  2002        PMID: 11932212     DOI: 10.1259/bjr.75.891.750207

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  41 in total

1.  Diffusion-weighted imaging of the spine: is it reliable?

Authors:  Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

2.  Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis.

Authors:  Fei Ai; Tao Ai; Xiaoming Li; Daoyu Hu; Wei Zhang; John N Morelli
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

3.  The role of magnetic resonance imaging in oncology.

Authors:  Concepción González Hernando; Laura Esteban; Teresa Cañas; Enrique Van den Brule; Miguel Pastrana
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 4.  Whole-body MR imaging, bone diffusion imaging: how and why?

Authors:  Diego Jaramillo
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 5.  Diffusion-weighted imaging in musculoskeletal radiology-clinical applications and future directions.

Authors:  Nicholas Bhojwani; Peter Szpakowski; Sasan Partovi; Martin H Maurer; Ulrich Grosse; Hendrik von Tengg-Kobligk; Lisa Zipp-Partovi; Nathan Fergus; Christos Kosmas; Konstantin Nikolaou; Mark R Robbin
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 6.  Resectability issues with head and neck cancer.

Authors:  D M Yousem; K Gad; R P Tufano
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 7.  Extracranial applications of diffusion-weighted magnetic resonance imaging.

Authors:  Harriet C Thoeny; Frederik De Keyzer
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

8.  Diffusion-weighted imaging of the spine with a non-carr-purcell-meiboom-gill single-shot fast spin-echo sequence: initial experience.

Authors:  A Y Oner; T Tali; F Celikyay; A Celik; P Le Roux
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

9.  Quantitative and diffusion MR imaging as a new method to assess osteoporosis.

Authors:  H G Hatipoglu; A Selvi; D Ciliz; E Yuksel
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-28       Impact factor: 3.825

Review 10.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.